Impact of antibiotics on gut microbiome composition and resistome in the first years of life in low- to middle-income countries: A systematic review
Inappropriate antimicrobial usage is a key driver of antimicrobial resistance (AMR). Low- and middle-income countries (LMICs) are disproportionately burdened by AMR and young children are especially vulnerable to infections with AMR-bearing pathogens. The impact of antibiotics on the microbiome, sel...
Saved in:
| Published in | PLoS medicine Vol. 20; no. 6; p. e1004235 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
27.06.2023
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1549-1676 1549-1277 1549-1676 |
| DOI | 10.1371/journal.pmed.1004235 |
Cover
Loading…
| Abstract | Inappropriate antimicrobial usage is a key driver of antimicrobial resistance (AMR). Low- and middle-income countries (LMICs) are disproportionately burdened by AMR and young children are especially vulnerable to infections with AMR-bearing pathogens. The impact of antibiotics on the microbiome, selection, persistence, and horizontal spread of AMR genes is insufficiently characterized and understood in children in LMICs. This systematic review aims to collate and evaluate the available literature describing the impact of antibiotics on the infant gut microbiome and resistome in LMICs.
In this systematic review, we searched the online databases MEDLINE (1946 to 28 January 2023), EMBASE (1947 to 28 January 2023), SCOPUS (1945 to 29 January 2023), WHO Global Index Medicus (searched up to 29 January 2023), and SciELO (searched up to 29 January 2023). A total of 4,369 articles were retrieved across the databases. Duplicates were removed resulting in 2,748 unique articles. Screening by title and abstract excluded 2,666 articles, 92 articles were assessed based on the full text, and 10 studies met the eligibility criteria that included human studies conducted in LMICs among children below the age of 2 that reported gut microbiome composition and/or resistome composition (AMR genes) following antibiotic usage. The included studies were all randomized control trials (RCTs) and were assessed for risk of bias using the Cochrane risk-of-bias for randomized studies tool. Overall, antibiotics reduced gut microbiome diversity and increased antibiotic-specific resistance gene abundance in antibiotic treatment groups as compared to the placebo. The most widely tested antibiotic was azithromycin that decreased the diversity of the gut microbiome and significantly increased macrolide resistance as early as 5 days posttreatment. A major limitation of this study was paucity of available studies that cover this subject area. Specifically, the range of antibiotics assessed did not include the most commonly used antibiotics in LMIC populations.
In this study, we observed that antibiotics significantly reduce the diversity and alter the composition of the infant gut microbiome in LMICs, while concomitantly selecting for resistance genes whose persistence can last for months following treatment. Considerable heterogeneity in study methodology, timing and duration of sampling, and sequencing methodology in currently available research limit insights into antibiotic impacts on the microbiome and resistome in children in LMICs. More research is urgently needed to fill this gap in order to better understand whether antibiotic-driven reductions in microbiome diversity and selection of AMR genes place LMIC children at risk for adverse health outcomes, including infections with AMR-bearing pathogens. |
|---|---|
| AbstractList | Inappropriate antimicrobial usage is a key driver of antimicrobial resistance (AMR). Low- and middle-income countries (LMICs) are disproportionately burdened by AMR and young children are especially vulnerable to infections with AMR-bearing pathogens. The impact of antibiotics on the microbiome, selection, persistence, and horizontal spread of AMR genes is insufficiently characterized and understood in children in LMICs. This systematic review aims to collate and evaluate the available literature describing the impact of antibiotics on the infant gut microbiome and resistome in LMICs. In this systematic review, we searched the online databases MEDLINE (1946 to 28 January 2023), EMBASE (1947 to 28 January 2023), SCOPUS (1945 to 29 January 2023), WHO Global Index Medicus (searched up to 29 January 2023), and SciELO (searched up to 29 January 2023). A total of 4,369 articles were retrieved across the databases. Duplicates were removed resulting in 2,748 unique articles. Screening by title and abstract excluded 2,666 articles, 92 articles were assessed based on the full text, and 10 studies met the eligibility criteria that included human studies conducted in LMICs among children below the age of 2 that reported gut microbiome composition and/or resistome composition (AMR genes) following antibiotic usage. The included studies were all randomized control trials (RCTs) and were assessed for risk of bias using the Cochrane risk-of-bias for randomized studies tool. Overall, antibiotics reduced gut microbiome diversity and increased antibiotic-specific resistance gene abundance in antibiotic treatment groups as compared to the placebo. The most widely tested antibiotic was azithromycin that decreased the diversity of the gut microbiome and significantly increased macrolide resistance as early as 5 days posttreatment. A major limitation of this study was paucity of available studies that cover this subject area. Specifically, the range of antibiotics assessed did not include the most commonly used antibiotics in LMIC populations. In this study, we observed that antibiotics significantly reduce the diversity and alter the composition of the infant gut microbiome in LMICs, while concomitantly selecting for resistance genes whose persistence can last for months following treatment. Considerable heterogeneity in study methodology, timing and duration of sampling, and sequencing methodology in currently available research limit insights into antibiotic impacts on the microbiome and resistome in children in LMICs. More research is urgently needed to fill this gap in order to better understand whether antibiotic-driven reductions in microbiome diversity and selection of AMR genes place LMIC children at risk for adverse health outcomes, including infections with AMR-bearing pathogens. Background Inappropriate antimicrobial usage is a key driver of antimicrobial resistance (AMR). Low- and middle-income countries (LMICs) are disproportionately burdened by AMR and young children are especially vulnerable to infections with AMR-bearing pathogens. The impact of antibiotics on the microbiome, selection, persistence, and horizontal spread of AMR genes is insufficiently characterized and understood in children in LMICs. This systematic review aims to collate and evaluate the available literature describing the impact of antibiotics on the infant gut microbiome and resistome in LMICs. Methods and findings In this systematic review, we searched the online databases MEDLINE (1946 to 28 January 2023), EMBASE (1947 to 28 January 2023), SCOPUS (1945 to 29 January 2023), WHO Global Index Medicus (searched up to 29 January 2023), and SciELO (searched up to 29 January 2023). A total of 4,369 articles were retrieved across the databases. Duplicates were removed resulting in 2,748 unique articles. Screening by title and abstract excluded 2,666 articles, 92 articles were assessed based on the full text, and 10 studies met the eligibility criteria that included human studies conducted in LMICs among children below the age of 2 that reported gut microbiome composition and/or resistome composition (AMR genes) following antibiotic usage. The included studies were all randomized control trials (RCTs) and were assessed for risk of bias using the Cochrane risk-of-bias for randomized studies tool. Overall, antibiotics reduced gut microbiome diversity and increased antibiotic-specific resistance gene abundance in antibiotic treatment groups as compared to the placebo. The most widely tested antibiotic was azithromycin that decreased the diversity of the gut microbiome and significantly increased macrolide resistance as early as 5 days posttreatment. A major limitation of this study was paucity of available studies that cover this subject area. Specifically, the range of antibiotics assessed did not include the most commonly used antibiotics in LMIC populations. Conclusion In this study, we observed that antibiotics significantly reduce the diversity and alter the composition of the infant gut microbiome in LMICs, while concomitantly selecting for resistance genes whose persistence can last for months following treatment. Considerable heterogeneity in study methodology, timing and duration of sampling, and sequencing methodology in currently available research limit insights into antibiotic impacts on the microbiome and resistome in children in LMICs. More research is urgently needed to fill this gap in order to better understand whether antibiotic-driven reductions in microbiome diversity and selection of AMR genes place LMIC children at risk for adverse health outcomes, including infections with AMR-bearing pathogens. Background Inappropriate antimicrobial usage is a key driver of antimicrobial resistance (AMR). Low- and middle-income countries (LMICs) are disproportionately burdened by AMR and young children are especially vulnerable to infections with AMR-bearing pathogens. The impact of antibiotics on the microbiome, selection, persistence, and horizontal spread of AMR genes is insufficiently characterized and understood in children in LMICs. This systematic review aims to collate and evaluate the available literature describing the impact of antibiotics on the infant gut microbiome and resistome in LMICs. Methods and findings In this systematic review, we searched the online databases MEDLINE (1946 to 28 January 2023), EMBASE (1947 to 28 January 2023), SCOPUS (1945 to 29 January 2023), WHO Global Index Medicus (searched up to 29 January 2023), and SciELO (searched up to 29 January 2023). A total of 4,369 articles were retrieved across the databases. Duplicates were removed resulting in 2,748 unique articles. Screening by title and abstract excluded 2,666 articles, 92 articles were assessed based on the full text, and 10 studies met the eligibility criteria that included human studies conducted in LMICs among children below the age of 2 that reported gut microbiome composition and/or resistome composition (AMR genes) following antibiotic usage. The included studies were all randomized control trials (RCTs) and were assessed for risk of bias using the Cochrane risk-of-bias for randomized studies tool. Overall, antibiotics reduced gut microbiome diversity and increased antibiotic-specific resistance gene abundance in antibiotic treatment groups as compared to the placebo. The most widely tested antibiotic was azithromycin that decreased the diversity of the gut microbiome and significantly increased macrolide resistance as early as 5 days posttreatment. A major limitation of this study was paucity of available studies that cover this subject area. Specifically, the range of antibiotics assessed did not include the most commonly used antibiotics in LMIC populations. Conclusion In this study, we observed that antibiotics significantly reduce the diversity and alter the composition of the infant gut microbiome in LMICs, while concomitantly selecting for resistance genes whose persistence can last for months following treatment. Considerable heterogeneity in study methodology, timing and duration of sampling, and sequencing methodology in currently available research limit insights into antibiotic impacts on the microbiome and resistome in children in LMICs. More research is urgently needed to fill this gap in order to better understand whether antibiotic-driven reductions in microbiome diversity and selection of AMR genes place LMIC children at risk for adverse health outcomes, including infections with AMR-bearing pathogens. Inappropriate antimicrobial usage is a key driver of antimicrobial resistance (AMR). Low- and middle-income countries (LMICs) are disproportionately burdened by AMR and young children are especially vulnerable to infections with AMR-bearing pathogens. The impact of antibiotics on the microbiome, selection, persistence, and horizontal spread of AMR genes is insufficiently characterized and understood in children in LMICs. This systematic review aims to collate and evaluate the available literature describing the impact of antibiotics on the infant gut microbiome and resistome in LMICs.BACKGROUNDInappropriate antimicrobial usage is a key driver of antimicrobial resistance (AMR). Low- and middle-income countries (LMICs) are disproportionately burdened by AMR and young children are especially vulnerable to infections with AMR-bearing pathogens. The impact of antibiotics on the microbiome, selection, persistence, and horizontal spread of AMR genes is insufficiently characterized and understood in children in LMICs. This systematic review aims to collate and evaluate the available literature describing the impact of antibiotics on the infant gut microbiome and resistome in LMICs.In this systematic review, we searched the online databases MEDLINE (1946 to 28 January 2023), EMBASE (1947 to 28 January 2023), SCOPUS (1945 to 29 January 2023), WHO Global Index Medicus (searched up to 29 January 2023), and SciELO (searched up to 29 January 2023). A total of 4,369 articles were retrieved across the databases. Duplicates were removed resulting in 2,748 unique articles. Screening by title and abstract excluded 2,666 articles, 92 articles were assessed based on the full text, and 10 studies met the eligibility criteria that included human studies conducted in LMICs among children below the age of 2 that reported gut microbiome composition and/or resistome composition (AMR genes) following antibiotic usage. The included studies were all randomized control trials (RCTs) and were assessed for risk of bias using the Cochrane risk-of-bias for randomized studies tool. Overall, antibiotics reduced gut microbiome diversity and increased antibiotic-specific resistance gene abundance in antibiotic treatment groups as compared to the placebo. The most widely tested antibiotic was azithromycin that decreased the diversity of the gut microbiome and significantly increased macrolide resistance as early as 5 days posttreatment. A major limitation of this study was paucity of available studies that cover this subject area. Specifically, the range of antibiotics assessed did not include the most commonly used antibiotics in LMIC populations.METHODS AND FINDINGSIn this systematic review, we searched the online databases MEDLINE (1946 to 28 January 2023), EMBASE (1947 to 28 January 2023), SCOPUS (1945 to 29 January 2023), WHO Global Index Medicus (searched up to 29 January 2023), and SciELO (searched up to 29 January 2023). A total of 4,369 articles were retrieved across the databases. Duplicates were removed resulting in 2,748 unique articles. Screening by title and abstract excluded 2,666 articles, 92 articles were assessed based on the full text, and 10 studies met the eligibility criteria that included human studies conducted in LMICs among children below the age of 2 that reported gut microbiome composition and/or resistome composition (AMR genes) following antibiotic usage. The included studies were all randomized control trials (RCTs) and were assessed for risk of bias using the Cochrane risk-of-bias for randomized studies tool. Overall, antibiotics reduced gut microbiome diversity and increased antibiotic-specific resistance gene abundance in antibiotic treatment groups as compared to the placebo. The most widely tested antibiotic was azithromycin that decreased the diversity of the gut microbiome and significantly increased macrolide resistance as early as 5 days posttreatment. A major limitation of this study was paucity of available studies that cover this subject area. Specifically, the range of antibiotics assessed did not include the most commonly used antibiotics in LMIC populations.In this study, we observed that antibiotics significantly reduce the diversity and alter the composition of the infant gut microbiome in LMICs, while concomitantly selecting for resistance genes whose persistence can last for months following treatment. Considerable heterogeneity in study methodology, timing and duration of sampling, and sequencing methodology in currently available research limit insights into antibiotic impacts on the microbiome and resistome in children in LMICs. More research is urgently needed to fill this gap in order to better understand whether antibiotic-driven reductions in microbiome diversity and selection of AMR genes place LMIC children at risk for adverse health outcomes, including infections with AMR-bearing pathogens.CONCLUSIONIn this study, we observed that antibiotics significantly reduce the diversity and alter the composition of the infant gut microbiome in LMICs, while concomitantly selecting for resistance genes whose persistence can last for months following treatment. Considerable heterogeneity in study methodology, timing and duration of sampling, and sequencing methodology in currently available research limit insights into antibiotic impacts on the microbiome and resistome in children in LMICs. More research is urgently needed to fill this gap in order to better understand whether antibiotic-driven reductions in microbiome diversity and selection of AMR genes place LMIC children at risk for adverse health outcomes, including infections with AMR-bearing pathogens. Inappropriate antimicrobial usage is a key driver of antimicrobial resistance (AMR). Low- and middle-income countries (LMICs) are disproportionately burdened by AMR and young children are especially vulnerable to infections with AMR-bearing pathogens. The impact of antibiotics on the microbiome, selection, persistence, and horizontal spread of AMR genes is insufficiently characterized and understood in children in LMICs. This systematic review aims to collate and evaluate the available literature describing the impact of antibiotics on the infant gut microbiome and resistome in LMICs. In this systematic review, we searched the online databases MEDLINE (1946 to 28 January 2023), EMBASE (1947 to 28 January 2023), SCOPUS (1945 to 29 January 2023), WHO Global Index Medicus (searched up to 29 January 2023), and SciELO (searched up to 29 January 2023). A total of 4,369 articles were retrieved across the databases. Duplicates were removed resulting in 2,748 unique articles. Screening by title and abstract excluded 2,666 articles, 92 articles were assessed based on the full text, and 10 studies met the eligibility criteria that included human studies conducted in LMICs among children below the age of 2 that reported gut microbiome composition and/or resistome composition (AMR genes) following antibiotic usage. The included studies were all randomized control trials (RCTs) and were assessed for risk of bias using the Cochrane risk-of-bias for randomized studies tool. Overall, antibiotics reduced gut microbiome diversity and increased antibiotic-specific resistance gene abundance in antibiotic treatment groups as compared to the placebo. The most widely tested antibiotic was azithromycin that decreased the diversity of the gut microbiome and significantly increased macrolide resistance as early as 5 days posttreatment. A major limitation of this study was paucity of available studies that cover this subject area. Specifically, the range of antibiotics assessed did not include the most commonly used antibiotics in LMIC populations. In this study, we observed that antibiotics significantly reduce the diversity and alter the composition of the infant gut microbiome in LMICs, while concomitantly selecting for resistance genes whose persistence can last for months following treatment. Considerable heterogeneity in study methodology, timing and duration of sampling, and sequencing methodology in currently available research limit insights into antibiotic impacts on the microbiome and resistome in children in LMICs. More research is urgently needed to fill this gap in order to better understand whether antibiotic-driven reductions in microbiome diversity and selection of AMR genes place LMIC children at risk for adverse health outcomes, including infections with AMR-bearing pathogens. Vanessa C Harris and colleagues review the currently available literature to report how antibiotic use in children from low- and middle-income countries impacts the gut microbiome and, the implications for antimicrobial resistant infections. Background Inappropriate antimicrobial usage is a key driver of antimicrobial resistance (AMR). Low- and middle-income countries (LMICs) are disproportionately burdened by AMR and young children are especially vulnerable to infections with AMR-bearing pathogens. The impact of antibiotics on the microbiome, selection, persistence, and horizontal spread of AMR genes is insufficiently characterized and understood in children in LMICs. This systematic review aims to collate and evaluate the available literature describing the impact of antibiotics on the infant gut microbiome and resistome in LMICs. Methods and findings In this systematic review, we searched the online databases MEDLINE (1946 to 28 January 2023), EMBASE (1947 to 28 January 2023), SCOPUS (1945 to 29 January 2023), WHO Global Index Medicus (searched up to 29 January 2023), and SciELO (searched up to 29 January 2023). A total of 4,369 articles were retrieved across the databases. Duplicates were removed resulting in 2,748 unique articles. Screening by title and abstract excluded 2,666 articles, 92 articles were assessed based on the full text, and 10 studies met the eligibility criteria that included human studies conducted in LMICs among children below the age of 2 that reported gut microbiome composition and/or resistome composition (AMR genes) following antibiotic usage. The included studies were all randomized control trials (RCTs) and were assessed for risk of bias using the Cochrane risk-of-bias for randomized studies tool. Overall, antibiotics reduced gut microbiome diversity and increased antibiotic-specific resistance gene abundance in antibiotic treatment groups as compared to the placebo. The most widely tested antibiotic was azithromycin that decreased the diversity of the gut microbiome and significantly increased macrolide resistance as early as 5 days posttreatment. A major limitation of this study was paucity of available studies that cover this subject area. Specifically, the range of antibiotics assessed did not include the most commonly used antibiotics in LMIC populations. Conclusion In this study, we observed that antibiotics significantly reduce the diversity and alter the composition of the infant gut microbiome in LMICs, while concomitantly selecting for resistance genes whose persistence can last for months following treatment. Considerable heterogeneity in study methodology, timing and duration of sampling, and sequencing methodology in currently available research limit insights into antibiotic impacts on the microbiome and resistome in children in LMICs. More research is urgently needed to fill this gap in order to better understand whether antibiotic-driven reductions in microbiome diversity and selection of AMR genes place LMIC children at risk for adverse health outcomes, including infections with AMR-bearing pathogens. Vanessa C Harris and colleagues review the currently available literature to report how antibiotic use in children from low- and middle-income countries impacts the gut microbiome and, the implications for antimicrobial resistant infections. Author summary Why was this study done? Antibiotics can disturb the bacteria in the gut and drive the development of antimicrobial resistance (AMR). Children in low- and middle-income (LMIC) settings often receive (inappropriate) antibiotics and are at risk of antimicrobial-resistant infections that are harder and costlier to treat. Currently, little knowledge exists regarding the risks of antibiotic use in children in LMIC and the impact of antibiotics on the bacteria in their gut. In this review, we aimed to identify studies evaluating the impact of antibiotics in children in LMIC to better describe these unintended antibiotic side effects. What did the researchers do and find? We systematically collected studies performed in LMIC in children that reported the effects of antibiotics on gut bacteria and profiled their antibiotic resistance genes. Our search revealed a paucity of published studies focusing on this topic and we identified only a handful of eligible studies to include in the review. We compared these studies based on the antibiotic used and differential impacts on gut bacteria, i.e., gut microbiome profiles and/or resistance genes. We observed that among children in LMIC, antibiotics generally reduced the numbers of bacterial taxa in the gut and increased the number of bacterial taxa with AMR. What do these findings mean? Our study shows that antibiotic use alters the microbiome composition in the gut and may adversely impact the health of children in LMIC, e.g., by placing them at risk of antimicrobial-resistant infections. More research is needed to understand how different antibiotics alter the gut microbiome and resistome of children in LMIC. Antibiotic usage in these populations should be better regulated, in order to prevent these indirect impacts of antibiotic use and reduce the risk of antimicrobial-resistant infections. |
| Audience | Academic |
| Author | Harris, Vanessa C. Chisenga, Caroline Spijker, Rene Bosomprah, Samuel Mende, Daniel R. Chibuye, Mwelwa Luchen, Charlie C. Simuyandi, Michelo Chilengi, Roma Schultsz, Constance |
| AuthorAffiliation | 7 Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology, Amsterdam, the Netherlands 3 Amsterdam Institute of Infection and Immunity, Infectious Diseases, Amsterdam University Medical Center, Amsterdam, the Netherlands 4 Department of Biostatistics, School of Public Health, University of Ghana, Accra, Ghana 8 Amsterdam UMC, location University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Amsterdam, the Netherlands 1 Amsterdam UMC, location University of Amsterdam, Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands 2 Research Division, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia 6 Republic of Zambia State House, Lusaka, Zambia 5 Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia |
| AuthorAffiliation_xml | – name: 5 Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia – name: 6 Republic of Zambia State House, Lusaka, Zambia – name: 1 Amsterdam UMC, location University of Amsterdam, Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands – name: 8 Amsterdam UMC, location University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Amsterdam, the Netherlands – name: 7 Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology, Amsterdam, the Netherlands – name: 4 Department of Biostatistics, School of Public Health, University of Ghana, Accra, Ghana – name: 2 Research Division, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia – name: 3 Amsterdam Institute of Infection and Immunity, Infectious Diseases, Amsterdam University Medical Center, Amsterdam, the Netherlands |
| Author_xml | – sequence: 1 givenname: Charlie C. orcidid: 0000-0002-3093-4635 surname: Luchen fullname: Luchen, Charlie C. – sequence: 2 givenname: Mwelwa orcidid: 0000-0002-7609-9698 surname: Chibuye fullname: Chibuye, Mwelwa – sequence: 3 givenname: Rene orcidid: 0000-0003-4445-1201 surname: Spijker fullname: Spijker, Rene – sequence: 4 givenname: Michelo orcidid: 0000-0002-7348-2835 surname: Simuyandi fullname: Simuyandi, Michelo – sequence: 5 givenname: Caroline orcidid: 0000-0002-7850-7915 surname: Chisenga fullname: Chisenga, Caroline – sequence: 6 givenname: Samuel orcidid: 0000-0002-2826-3887 surname: Bosomprah fullname: Bosomprah, Samuel – sequence: 7 givenname: Roma surname: Chilengi fullname: Chilengi, Roma – sequence: 8 givenname: Constance orcidid: 0000-0003-2280-7844 surname: Schultsz fullname: Schultsz, Constance – sequence: 9 givenname: Daniel R. orcidid: 0000-0001-6831-4557 surname: Mende fullname: Mende, Daniel R. – sequence: 10 givenname: Vanessa C. orcidid: 0000-0002-4881-5263 surname: Harris fullname: Harris, Vanessa C. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37368871$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVk9tq3DAQhk1JaQ7tG5RWUCjthbeWZVve3JQl9LAQGujpVsjSaFdBtjaWnDTv0QfuOLsJ2bCUFl9YzHzzz2hGc5jsdb6DJHlOswllnL4790PfSTdZtaAnNMuKnJWPkgNaFtOUVrzau3feTw5DOM-yfJpNsyfJPuOsqmtOD5Lf83YlVSTeENlF21gfrQrEd2QxRNJa1Xu0tUCUb1c-2GjRJTtNegg2xNFjOxKXQIztQyTXIPswqjlrblzOX6UkepTS2kFqO7VWG7rYWwjHZEbCdYjQSkyMqpcWrp4mj410AZ5t_kfJj48fvp98Tk_PPs1PZqep4lUZUw5TbjQYNjVaVtBIVtc6K3WhmlrqplYcFGUSuM5VXUJdKEnzRpkCmtLggR0lL9e6K-eD2DQ0iLxmNcsZ9geJ-ZrQXp6LVW9b2V8LL624Mfh-IWSPhTsQJTNlQSnX0mSYqZrWoEuqZVnmKqe6RK33m2xDgzNTgB2Qbkt029PZpVj4S0FxbjXnDBXebBR6fzFAiKK1QYFzsgM_3BSeVRWrqhzRVw_Q3dfbUAuJN7Cd8ZhYjaJixsuKZXlRjVS6g1pAB1glPkpj0bzFT3bw-GnAB7Uz4O1WADIRfsWFHEIQ829f_4P98u_s2c9t9vU9dgnSxWXwbhgffNgGX9wf4938bncKgWIN4O6E0IO5Q2gmxtW9HYUYV1dsVhfDjh-EKRvlmB67Z93fg_8A001L3w |
| CitedBy_id | crossref_primary_10_1038_s41598_024_75319_y crossref_primary_10_1002_jobm_202400330 crossref_primary_10_1111_1751_7915_70041 crossref_primary_10_1038_s41522_024_00562_0 crossref_primary_10_1016_j_jad_2024_10_042 crossref_primary_10_1016_j_chemosphere_2025_144263 crossref_primary_10_3390_jpm14020217 crossref_primary_10_3390_pathogens13080624 crossref_primary_10_1080_19490976_2023_2297837 crossref_primary_10_1038_s41579_024_01041_1 crossref_primary_10_3399_BJGPO_2024_0032 crossref_primary_10_3390_antibiotics14030310 crossref_primary_10_1093_infdis_jiae542 crossref_primary_10_1080_19490976_2024_2383746 crossref_primary_10_3389_fmed_2024_1477882 crossref_primary_10_1080_19490976_2024_2356279 crossref_primary_10_1038_s41587_024_02493_9 crossref_primary_10_1039_D4FO00724G |
| Cites_doi | 10.1093/ofid/ofy289 10.1080/19490976.2020.1848158 10.4269/ajtmh.19-0940 10.1056/NEJMoa2023294 10.1038/s41564-019-0550-2 10.1016/j.tim.2018.09.008 10.3389/fmicb.2017.01162 10.1056/NEJMoa1205037 10.1099/jmm.0.000568 10.1016/j.celrep.2022.110649 10.1186/1471-2334-14-13 10.1016/j.chom.2018.07.005 10.1136/bmj.l4898 10.1016/j.jembe.2005.12.017 10.1056/NEJMoa2002606 10.1136/bmj.g2267 10.1128/CMR.00116-14 10.1007/s12519-018-00223-1 10.1016/S0140-6736(05)17907-0 10.1542/peds.2008-1146 10.1093/ofid/ofy182 10.1038/s41564-019-0640-1 10.1093/cid/cir069 10.1016/j.archoralbio.2020.104730 10.1038/nature03891 10.1016/S2542-5196(21)00280-1 10.1038/s41591-019-0533-0 10.1016/j.jpeds.2015.08.015 10.1111/obr.12717 10.1128/mBio.02820-19 10.1038/nri3535 10.1016/j.cell.2014.05.052 10.1038/s41598-017-06862-0 10.1056/NEJMoa1715474 10.1093/cid/ciz455 10.1080/19490976.2016.1218584 10.1542/peds.2018-0290 10.7554/eLife.39435 10.1053/j.gastro.2016.03.006 10.1016/S1473-3099(17)30467-X 10.1056/NEJMoa1817213 10.3390/microorganisms7090363 10.1056/NEJMra1600266 10.1038/s41385-022-00544-5 10.3390/antibiotics11040470 10.1016/S1473-3099(19)30572-9 10.1016/S2214-109X(21)00024-3 10.4014/jmb.1709.09027 10.1186/s13099-021-00478-6 10.1016/j.ebiom.2018.11.035 10.1038/s41467-022-28525-z 10.1093/cid/ciz1186 10.1001/jama.2009.1266 10.1080/19490976.2020.1870402 10.1186/s13643-016-0384-4 10.3389/fmicb.2018.01037 10.1016/S0140-6736(21)02724-0 10.1186/s12879-017-2713-1 10.1038/nature07250 10.1371/journal.pone.0161654 10.1038/nrmicro1614 10.1093/cid/cix141 |
| ContentType | Journal Article |
| Copyright | Copyright: © 2023 Luchen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. COPYRIGHT 2023 Public Library of Science 2023 Luchen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023 Luchen et al 2023 Luchen et al |
| Copyright_xml | – notice: Copyright: © 2023 Luchen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. – notice: COPYRIGHT 2023 Public Library of Science – notice: 2023 Luchen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023 Luchen et al 2023 Luchen et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISN ISR 3V. 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA CZK |
| DOI | 10.1371/journal.pmed.1004235 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Canada Gale In Context: Science ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals PLoS Medicine |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Systematic review of antibiotic impacts on the infant gut microbiome and resistome in LMIC |
| EISSN | 1549-1676 |
| ExternalDocumentID | 2838323871 oai_doaj_org_article_53f54117daf04ca698ed51da552c21d5 PMC10298773 A756302461 37368871 10_1371_journal_pmed_1004235 |
| Genre | Research Support, Non-U.S. Gov't Systematic Review Journal Article |
| GeographicLocations | Burkina Faso |
| GeographicLocations_xml | – name: Burkina Faso |
| GrantInformation_xml | – fundername: Wellcome Trust – fundername: ; grantid: 10430022010019 – fundername: ; grantid: GLORIA – fundername: ; grantid: 219775/Z/19/Z – fundername: ; grantid: 09150161810022 |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAUCC AAWOE AAWTL AAYXX ABDBF ABUWG ACGFO ACIHN ACPRK ACUHS ADBBV AEAQA AENEX AFKRA AFPKN AFRAH AFXKF AHMBA AKRSQ ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS B0M BAWUL BCNDV BENPR BPHCQ BVXVI BWKFM CCPQU CITATION CS3 DIK DU5 E3Z EAP EAS EBD EBS EJD EMK EMOBN ESX F5P FPL FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR IOF IOV IPO ISN ISR ITC KQ8 M1P M48 MK0 O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PV9 RNS RPM RZL SV3 TR2 TUS UKHRP WOW XSB YZZ ~8M ADRAZ CGR CUY CVF ECM EIF H13 IPNFZ NPM RIG WOQ PMFND 3V. 7TK 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO AAPBV ABPTK BCGST CZK ICW M~E |
| ID | FETCH-LOGICAL-c765t-7e97fdef39fda6eba388d05d4cb8adb8c7ec13ae7d2c85e84ca12bcf4eb5f2bc3 |
| IEDL.DBID | M48 |
| ISSN | 1549-1676 1549-1277 |
| IngestDate | Sun Aug 06 00:45:55 EDT 2023 Wed Aug 27 01:15:04 EDT 2025 Thu Aug 21 18:37:29 EDT 2025 Fri Jul 11 12:24:47 EDT 2025 Fri Jul 25 09:16:09 EDT 2025 Tue Jun 17 21:33:58 EDT 2025 Fri Jun 13 00:09:36 EDT 2025 Tue Jun 10 21:27:24 EDT 2025 Fri Jun 27 06:05:18 EDT 2025 Fri Jun 27 05:51:24 EDT 2025 Fri Jun 27 05:49:12 EDT 2025 Thu May 22 21:22:41 EDT 2025 Thu Apr 03 06:57:03 EDT 2025 Tue Jul 01 04:28:46 EDT 2025 Thu Apr 24 23:06:43 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Language | English |
| License | Copyright: © 2023 Luchen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c765t-7e97fdef39fda6eba388d05d4cb8adb8c7ec13ae7d2c85e84ca12bcf4eb5f2bc3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Undefined-1 content type line 23 The authors have declared that no competing interests exist. |
| ORCID | 0000-0002-7850-7915 0000-0001-6831-4557 0000-0002-7348-2835 0000-0002-4881-5263 0000-0003-4445-1201 0000-0003-2280-7844 0000-0002-7609-9698 0000-0002-2826-3887 0000-0002-3093-4635 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pmed.1004235 |
| PMID | 37368871 |
| PQID | 2838323871 |
| PQPubID | 1436338 |
| ParticipantIDs | plos_journals_2838323871 doaj_primary_oai_doaj_org_article_53f54117daf04ca698ed51da552c21d5 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10298773 proquest_miscellaneous_2830663662 proquest_journals_2838323871 gale_infotracmisc_A756302461 gale_infotracgeneralonefile_A756302461 gale_infotracacademiconefile_A756302461 gale_incontextgauss_ISR_A756302461 gale_incontextgauss_ISN_A756302461 gale_incontextgauss_IOV_A756302461 gale_healthsolutions_A756302461 pubmed_primary_37368871 crossref_primary_10_1371_journal_pmed_1004235 crossref_citationtrail_10_1371_journal_pmed_1004235 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20230627 |
| PublicationDateYYYYMMDD | 2023-06-27 |
| PublicationDate_xml | – month: 6 year: 2023 text: 20230627 day: 27 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PLoS medicine |
| PublicationTitleAlternate | PLoS Med |
| PublicationYear | 2023 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | AJ Mathers (pmed.1004235.ref035) 2015; 28 F Marra (pmed.1004235.ref028) 2009; 123 T Doan (pmed.1004235.ref046) 2020; 383 JD Keenan (pmed.1004235.ref021) 2011; 52 M Ouzzani (pmed.1004235.ref038) 2016; 5 BT Tadesse (pmed.1004235.ref010) 2017; 17 RY Chen (pmed.1004235.ref029) 2021; 384 JD Keenan (pmed.1004235.ref012) 2018; 378 H Pickering (pmed.1004235.ref049) 2022; 14 CJ Murray (pmed.1004235.ref004) 2022; 399 RC Robertson (pmed.1004235.ref031) 2019; 27 FI Scott (pmed.1004235.ref027) 2016; 151 JP Block (pmed.1004235.ref023) 2018; 142 SA Miller (pmed.1004235.ref025) 2018; 19 J. O’Neill (pmed.1004235.ref002) 2014 E van Nood (pmed.1004235.ref056) 2013; 368 C Roubaud-Baudron (pmed.1004235.ref055) 2019; 10 L McDonnell (pmed.1004235.ref037) 2021; 13 University of California, San Francisco (pmed.1004235.ref064) 2021 ET Rogawski (pmed.1004235.ref026) 2015; 167 O Jonas (pmed.1004235.ref001) 2017 RP Sequeira (pmed.1004235.ref019) 2020; 5 TC Porco (pmed.1004235.ref022) 2009; 302 H Wu (pmed.1004235.ref020) 2020; 114 CE Oldenburg (pmed.1004235.ref050) 2020; 70 CE Oldenburg (pmed.1004235.ref048) 2018; 5 ESAC Project Group (pmed.1004235.ref007) 2005; 365 AJ Browne (pmed.1004235.ref009) 2021; 5 KR Clarke (pmed.1004235.ref042) 2006; 330 A Hinterwirth (pmed.1004235.ref047) 2020; 103 JD Keenan (pmed.1004235.ref013) 2019; 380 LM Cox (pmed.1004235.ref060) 2014; 158 Y Kwon (pmed.1004235.ref065) 2022; 11 BG Bell (pmed.1004235.ref006) 2014; 14 AW D’Souza (pmed.1004235.ref015) 2020; 71 TD Clausen (pmed.1004235.ref030) 2016; 11 H Zafar (pmed.1004235.ref052); 13 GD Fink (pmed.1004235.ref014) 2020; 20 BD Wagner (pmed.1004235.ref040) 2018; 9 WE Anthony (pmed.1004235.ref053) 2022; 39 NTT Do (pmed.1004235.ref058) 2021; 9 EK Gough (pmed.1004235.ref032) 2014; 348 University of California, San Francisco (pmed.1004235.ref063) 2020 AJ Gasparrini (pmed.1004235.ref016) 2016; 7 SW Olesen (pmed.1004235.ref008) 2018; 7 JM Bello-López (pmed.1004235.ref034) 2019; 7 L Bai (pmed.1004235.ref067) 2017; 66 GD Wright (pmed.1004235.ref033) 2007; 5 D Kelly (pmed.1004235.ref024) 2019; 15 AJ Gasparrini (pmed.1004235.ref017) 2019; 4 M Reyman (pmed.1004235.ref068) 2022; 13 World Health Organisation (pmed.1004235.ref005) 2021 CG Buffie (pmed.1004235.ref018) 2013; 13 S Wei (pmed.1004235.ref066) 2018; 38 T Doan (pmed.1004235.ref043) 2017; 64 PCM Williams (pmed.1004235.ref011) 2018; 18 VK Gupta (pmed.1004235.ref036) 2017; 8 B-R Kim (pmed.1004235.ref041) 2017; 27 T Bell (pmed.1004235.ref062) 2005; 436 EPK Parker (pmed.1004235.ref051) 2017; 7 TC Borbet (pmed.1004235.ref061) 2022; 15 JAC Sterne (pmed.1004235.ref039) 2019; 366 T Doan (pmed.1004235.ref044) 2018; 5 T Doan (pmed.1004235.ref045) 2019; 25 K Brandl (pmed.1004235.ref057) 2008; 455 J. O’Neill (pmed.1004235.ref003) 2016 VC Harris (pmed.1004235.ref054) 2018; 24 SV Lynch (pmed.1004235.ref059) 2016; 375 |
| References_xml | – volume: 5 start-page: ofy289 year: 2018 ident: pmed.1004235.ref048 article-title: Effect of Commonly Used Pediatric Antibiotics on Gut Microbial Diversity in Preschool Children in Burkina Faso: A Randomized Clinical Trial publication-title: Open Forum. Infect Dis doi: 10.1093/ofid/ofy289 – volume: 13 start-page: 1848158 ident: pmed.1004235.ref052 article-title: Gut Bacteroides species in health and disease publication-title: Gut Microbes doi: 10.1080/19490976.2020.1848158 – volume: 103 start-page: 1266 year: 2020 ident: pmed.1004235.ref047 article-title: Rapid Reduction of Campylobacter Species in the Gut Microbiome of Preschool Children after Oral Azithromycin: A Randomized Controlled Trial publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.19-0940 – volume-title: Evaluating Impact of Azithromycin Mass Drug Administrations on All-cause Mortality and Antibiotic Resistance: Mortality Trial year: 2020 ident: pmed.1004235.ref063 – volume: 384 start-page: 1517 year: 2021 ident: pmed.1004235.ref029 article-title: A Microbiota-Directed Food Intervention for Undernourished Children publication-title: N Engl J Med doi: 10.1056/NEJMoa2023294 – volume: 4 start-page: 2285 year: 2019 ident: pmed.1004235.ref017 article-title: Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome publication-title: Nat Microbiol doi: 10.1038/s41564-019-0550-2 – volume: 27 start-page: 131 year: 2019 ident: pmed.1004235.ref031 article-title: The Human Microbiome and Child Growth–First 1000 Days and Beyond publication-title: Trends Microbiol doi: 10.1016/j.tim.2018.09.008 – volume: 8 year: 2017 ident: pmed.1004235.ref036 article-title: Geography, Ethnicity or Subsistence-Specific Variations in Human Microbiome Composition and Diversity. publication-title: Front Microbiol. doi: 10.3389/fmicb.2017.01162 – volume: 368 start-page: 407 year: 2013 ident: pmed.1004235.ref056 article-title: Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile publication-title: N Engl J Med doi: 10.1056/NEJMoa1205037 – volume: 66 start-page: 1297 year: 2017 ident: pmed.1004235.ref067 article-title: Changes in the gastrointestinal microbiota of children with acute lymphoblastic leukaemia and its association with antibiotics in the short term publication-title: J Med Microbiol doi: 10.1099/jmm.0.000568 – year: 2021 ident: pmed.1004235.ref005 publication-title: Antimicrobial resistance – volume: 39 start-page: 110649 year: 2022 ident: pmed.1004235.ref053 article-title: Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults publication-title: Cell Rep doi: 10.1016/j.celrep.2022.110649 – volume: 14 start-page: 13 year: 2014 ident: pmed.1004235.ref006 article-title: A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. publication-title: BMC Infect Dis doi: 10.1186/1471-2334-14-13 – volume: 24 start-page: 197 year: 2018 ident: pmed.1004235.ref054 article-title: Effect of Antibiotic-Mediated Microbiome Modulation on Rotavirus Vaccine Immunogenicity: A Human Randomized-Control Proof-of-Concept Trial publication-title: Cell Host Microbe doi: 10.1016/j.chom.2018.07.005 – volume: 366 start-page: l4898 year: 2019 ident: pmed.1004235.ref039 article-title: RoB 2: a revised tool for assessing risk of bias in randomised trials publication-title: BMJ doi: 10.1136/bmj.l4898 – volume: 330 start-page: 55 year: 2006 ident: pmed.1004235.ref042 article-title: On resemblance measures for ecological studies, including taxonomic dissimilarities and a zero-adjusted Bray–Curtis coefficient for denuded assemblages publication-title: J Exp Mar Biol Ecol doi: 10.1016/j.jembe.2005.12.017 – volume: 383 start-page: 1941 year: 2020 ident: pmed.1004235.ref046 article-title: Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution publication-title: N Engl J Med doi: 10.1056/NEJMoa2002606 – volume-title: Tackling drug-resistant infections globally: final report and recommendations year: 2016 ident: pmed.1004235.ref003 – volume: 348 start-page: g2267 year: 2014 ident: pmed.1004235.ref032 article-title: The impact of antibiotics on growth in children in low and middle income countries: systematic review and meta-analysis of randomised controlled trials publication-title: BMJ doi: 10.1136/bmj.g2267 – volume: 28 start-page: 565 year: 2015 ident: pmed.1004235.ref035 article-title: The Role of Epidemic Resistance Plasmids and International High-Risk Clones in the Spread of Multidrug-Resistant Enterobacteriaceae publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00116-14 – volume-title: HNP/Agriculture Global Antimicrobial Resistance Initiative year: 2017 ident: pmed.1004235.ref001 – volume: 15 start-page: 390 year: 2019 ident: pmed.1004235.ref024 article-title: Antibiotic use in early childhood and risk of obesity: longitudinal analysis of a national cohort publication-title: World J Pediatr doi: 10.1007/s12519-018-00223-1 – volume: 365 start-page: 579 year: 2005 ident: pmed.1004235.ref007 article-title: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study publication-title: Lancet Lond Engl doi: 10.1016/S0140-6736(05)17907-0 – volume: 123 start-page: 1003 year: 2009 ident: pmed.1004235.ref028 article-title: Antibiotic use in children is associated with increased risk of asthma publication-title: Pediatrics doi: 10.1542/peds.2008-1146 – volume: 5 start-page: ofy182 year: 2018 ident: pmed.1004235.ref044 article-title: Mass Azithromycin Distribution and Community Microbiome: A Cluster-Randomized Trial publication-title: Open Forum. Infect Dis doi: 10.1093/ofid/ofy182 – volume: 5 start-page: 304 year: 2020 ident: pmed.1004235.ref019 article-title: Commensal Bacteroidetes protect against Klebsiella pneumoniae colonization and transmission through IL-36 signalling. publication-title: Nat Microbiol. doi: 10.1038/s41564-019-0640-1 – volume: 52 start-page: 883 year: 2011 ident: pmed.1004235.ref021 article-title: Childhood mortality in a cohort treated with mass azithromycin for trachoma publication-title: Clin Infect Dis Off Publ Infect Dis Soc Am doi: 10.1093/cid/cir069 – volume: 114 start-page: 104730 year: 2020 ident: pmed.1004235.ref020 article-title: Antibiotic-induced dysbiosis of the rat oral and gut microbiota and resistance to Salmonella publication-title: Arch Oral Biol doi: 10.1016/j.archoralbio.2020.104730 – volume: 436 start-page: 1157 year: 2005 ident: pmed.1004235.ref062 article-title: The contribution of species richness and composition to bacterial services publication-title: Nature doi: 10.1038/nature03891 – volume: 5 start-page: e893 year: 2021 ident: pmed.1004235.ref009 article-title: Global antibiotic consumption and usage in humans, 2000–18: a spatial modelling study publication-title: Lancet Planet Health doi: 10.1016/S2542-5196(21)00280-1 – volume: 25 start-page: 1370 year: 2019 ident: pmed.1004235.ref045 article-title: Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution publication-title: Nat Med doi: 10.1038/s41591-019-0533-0 – volume: 167 start-page: 1096 year: 2015 ident: pmed.1004235.ref026 article-title: Early Life Antibiotic Exposure Is Not Associated with Growth in Young Children of Vellore, India publication-title: J Pediatr doi: 10.1016/j.jpeds.2015.08.015 – volume: 19 start-page: 1463 year: 2018 ident: pmed.1004235.ref025 article-title: The association between antibiotic use in infancy and childhood overweight or obesity: a systematic review and meta-analysis. publication-title: Obes Rev Off J Int Assoc Study Obes doi: 10.1111/obr.12717 – volume: 10 start-page: e02820 year: 2019 ident: pmed.1004235.ref055 article-title: Long-Term Effects of Early-Life Antibiotic Exposure on Resistance to Subsequent Bacterial Infection. publication-title: mBio. doi: 10.1128/mBio.02820-19 – volume: 13 start-page: 790 year: 2013 ident: pmed.1004235.ref018 article-title: Microbiota-mediated colonization resistance against intestinal pathogens publication-title: Nat Rev Immunol doi: 10.1038/nri3535 – volume: 158 start-page: 705 year: 2014 ident: pmed.1004235.ref060 article-title: Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences publication-title: Cell doi: 10.1016/j.cell.2014.05.052 – volume: 7 start-page: 9168 year: 2017 ident: pmed.1004235.ref051 article-title: Changes in the intestinal microbiota following the administration of azithromycin in a randomised placebo-controlled trial among infants in south India. publication-title: Sci Rep. doi: 10.1038/s41598-017-06862-0 – volume-title: Antibiotic Resistance and Microbiome in Children Aged 6–59 Months in Nouna, Burkina Faso. year: 2021 ident: pmed.1004235.ref064 – volume: 378 start-page: 1583 year: 2018 ident: pmed.1004235.ref012 article-title: Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa publication-title: N Engl J Med doi: 10.1056/NEJMoa1715474 – volume: 70 start-page: 525 year: 2020 ident: pmed.1004235.ref050 article-title: Gut Resistome After Oral Antibiotics in Preschool Children in Burkina Faso: A Randomized, Controlled Trial publication-title: Clin Infect Dis Off Publ Infect Dis Soc Am doi: 10.1093/cid/ciz455 – volume: 7 start-page: 443 year: 2016 ident: pmed.1004235.ref016 article-title: Antibiotic perturbation of the preterm infant gut microbiome and resistome publication-title: Gut Microbes doi: 10.1080/19490976.2016.1218584 – volume: 142 start-page: e20180290 year: 2018 ident: pmed.1004235.ref023 article-title: Early Antibiotic Exposure and Weight Outcomes in Young Children publication-title: Pediatrics doi: 10.1542/peds.2018-0290 – volume: 7 start-page: e39435 year: 2018 ident: pmed.1004235.ref008 article-title: The distribution of antibiotic use and its association with antibiotic resistance. publication-title: eLife. doi: 10.7554/eLife.39435 – volume: 151 start-page: 120 year: 2016 ident: pmed.1004235.ref027 article-title: Administration of Antibiotics to Children Before Age 2 Years Increases Risk for Childhood Obesity publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.03.006 – volume: 18 start-page: e33 year: 2018 ident: pmed.1004235.ref011 article-title: Antimicrobial resistance among children in sub-Saharan Africa publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(17)30467-X – volume: 380 start-page: 2207 year: 2019 ident: pmed.1004235.ref013 article-title: Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa publication-title: N Engl J Med doi: 10.1056/NEJMoa1817213 – year: 2014 ident: pmed.1004235.ref002 article-title: Review on Antimicrobial Resistance Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations publication-title: Rev Antimicrob Resist. – volume: 7 start-page: 363 year: 2019 ident: pmed.1004235.ref034 article-title: Horizontal Gene Transfer and Its Association with Antibiotic Resistance in the Genus Aeromonas spp publication-title: Microorganisms doi: 10.3390/microorganisms7090363 – volume: 375 start-page: 2369 year: 2016 ident: pmed.1004235.ref059 article-title: The Human Intestinal Microbiome in Health and Disease publication-title: N Engl J Med doi: 10.1056/NEJMra1600266 – volume: 15 start-page: 1000 year: 2022 ident: pmed.1004235.ref061 article-title: Influence of the early-life gut microbiota on the immune responses to an inhaled allergen publication-title: Mucosal Immunol doi: 10.1038/s41385-022-00544-5 – volume: 11 start-page: 470 year: 2022 ident: pmed.1004235.ref065 article-title: Changes to Gut Microbiota Following Systemic Antibiotic Administration in Infants publication-title: Antibiotics doi: 10.3390/antibiotics11040470 – volume: 20 start-page: 179 year: 2020 ident: pmed.1004235.ref014 article-title: Antibiotic exposure among children younger than 5 years in low-income and middle-income countries: a cross-sectional study of nationally representative facility-based and household-based surveys publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(19)30572-9 – volume: 9 start-page: e610 year: 2021 ident: pmed.1004235.ref058 article-title: Community-based antibiotic access and use in six low-income and middle-income countries: a mixed-method approach publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(21)00024-3 – volume: 27 start-page: 2089 year: 2017 ident: pmed.1004235.ref041 article-title: Deciphering Diversity Indices for a Better Understanding of Microbial Communities publication-title: J Microbiol Biotechnol doi: 10.4014/jmb.1709.09027 – volume: 14 start-page: 5 year: 2022 ident: pmed.1004235.ref049 article-title: Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial. publication-title: Gut Pathog. doi: 10.1186/s13099-021-00478-6 – volume: 38 start-page: 265 year: 2018 ident: pmed.1004235.ref066 article-title: Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: A double-blind, randomized, placebo-controlled trial. publication-title: EBioMedicine. doi: 10.1016/j.ebiom.2018.11.035 – volume: 13 start-page: 893 year: 2022 ident: pmed.1004235.ref068 article-title: Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial publication-title: Nat Commun doi: 10.1038/s41467-022-28525-z – volume: 71 start-page: 2858 year: 2020 ident: pmed.1004235.ref015 article-title: Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus–Exposed, Uninfected Infants publication-title: Clin Infect Dis doi: 10.1093/cid/ciz1186 – volume: 302 start-page: 962 year: 2009 ident: pmed.1004235.ref022 article-title: Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial publication-title: JAMA doi: 10.1001/jama.2009.1266 – volume: 13 start-page: 1 year: 2021 ident: pmed.1004235.ref037 article-title: Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis publication-title: Gut Microbes doi: 10.1080/19490976.2020.1870402 – volume: 5 start-page: 210 year: 2016 ident: pmed.1004235.ref038 article-title: Rayyan—a web and mobile app for systematic reviews. publication-title: Syst Rev. doi: 10.1186/s13643-016-0384-4 – volume: 9 start-page: 1037 year: 2018 ident: pmed.1004235.ref040 article-title: On the Use of Diversity Measures in Longitudinal Sequencing Studies of Microbial Communities. publication-title: Front Microbiol. doi: 10.3389/fmicb.2018.01037 – volume: 399 start-page: 629 year: 2022 ident: pmed.1004235.ref004 article-title: Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis publication-title: Lancet doi: 10.1016/S0140-6736(21)02724-0 – volume: 17 year: 2017 ident: pmed.1004235.ref010 article-title: Antimicrobial resistance in Africa: a systematic review. publication-title: BMC Infect Dis. doi: 10.1186/s12879-017-2713-1 – volume: 455 start-page: 804 year: 2008 ident: pmed.1004235.ref057 article-title: Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits publication-title: Nature doi: 10.1038/nature07250 – volume: 11 start-page: e0161654 year: 2016 ident: pmed.1004235.ref030 article-title: Broad-Spectrum Antibiotic Treatment and Subsequent Childhood Type 1 Diabetes: A Nationwide Danish Cohort Study publication-title: PLoS ONE doi: 10.1371/journal.pone.0161654 – volume: 5 start-page: 175 year: 2007 ident: pmed.1004235.ref033 article-title: The antibiotic resistome: the nexus of chemical and genetic diversity publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro1614 – volume: 64 start-page: 1147 year: 2017 ident: pmed.1004235.ref043 article-title: Gut Microbial Diversity in Antibiotic-Naive Children After Systemic Antibiotic Exposure: A Randomized Controlled Trial publication-title: Clin Infect Dis Off Publ Infect Dis Soc Am doi: 10.1093/cid/cix141 |
| SSID | ssj0029090 |
| Score | 2.5351856 |
| SecondaryResourceType | review_article |
| Snippet | Inappropriate antimicrobial usage is a key driver of antimicrobial resistance (AMR). Low- and middle-income countries (LMICs) are disproportionately burdened... Background Inappropriate antimicrobial usage is a key driver of antimicrobial resistance (AMR). Low- and middle-income countries (LMICs) are disproportionately... Vanessa C Harris and colleagues review the currently available literature to report how antibiotic use in children from low- and middle-income countries... Background Inappropriate antimicrobial usage is a key driver of antimicrobial resistance (AMR). Low- and middle-income countries (LMICs) are disproportionately... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e1004235 |
| SubjectTerms | Analysis Anti-Bacterial Agents - adverse effects Antibiotics Antimicrobial agents Antimicrobial resistance Azithromycin Bias Biology and Life Sciences Child Child, Preschool Children Composition Developing Countries Digestive system Disease susceptibility Dosage and administration Drug resistance Drug resistance in microorganisms Drug Resistance, Microbial - genetics Earth Sciences Gastrointestinal Microbiome - genetics Genes Gut microbiota Health aspects Humans Infant Infants Infectious diseases Intestinal microflora Medicine and Health Sciences Microbiomes Microbiota Microbiota (Symbiotic organisms) Mortality Online databases Pathogens Population studies Prevention Reviews Social Sciences Systematic review Taxonomy |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQHhAXxLsLBQxCcDLdxEns5bYgqhapRQKKeov83EbaJiuyq6r_gx_MjOMNDVqpPXCLMp8tZcb2zDjjz4S8UVKqNHEZm3ijWaaVZdo4w2xqvAN_XRRhM-fouDg4yb6c5qdXrvrCmrCOHrhT3F7OfZ4libDKTzKjiql0Nk-syvPUpIkN7KXg8zbJVEy1ppOwu4L8YyxJhYiH5rhI9qKN3i_B22CNAMQT-cApBe7-foUeLRdNuy38_LeK8opb2r9H7sZ4ks6677hPbrn6Abl9FP-YPyS_D8MxSNp4CjqsdNUgLzNtajpfr-h51fEwnTuKteWxgAuQlkIajqwDIKlqClEi9RUEivQSZkaLvS0qH0SL5oLRVQNd4U4HQ7KH0Nu6xqu62g90Rv-yRdPupMwjcrL_-cenAxZvYmBGFPmKCTcV3jrPp96qwmnFpbST3GZGS2W1NMKZhCsnwMQydxIMlaTa-Mzp3MMDf0xGdVO7HUIzITTXEHRY7jMYG3JiIUkpTAGtUyXVmPCNKUoTacrxtoxFGf69CUhXOs2WaMAyGnBMWN9q2dF0XIP_iFbusUiyHV7A0Cvj0CuvG3pj8hLHSNmdWO2XinImkHQNifrG5HVAoO5rrOSZq3Xblodff94A9P34JqBvA9C7CPIN6MyoeMQCNI8sXwPk2wFy3nGcbwPuDoCw-JiBeAfnx0bHbQnRKvgIDmk4tNzMme3iV70YO8Vav9o164DBOLgo0jF50k2x3k5c8EKG1nIw-QaGHErq6iywpid42YAQ_On_MP0zcieFaBdrBlOxS0arX2v3HKLTlX4RFqI_pM-QKg priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegSIgXxPcKAwxC8GTWxEns8oIKYtqQNiRgaG-RP7tIXVKWVoj_gz-YO8dtCapgb1XvZ6u9853P9vlnQl4oKVWauIyNvNEs08oybZxhNjXewXxdFGEz5-i4ODjJPp7mp3HDrY1llauYGAK1bQzuke_BNAiDj0N-_3b-neGrUXi6Gp_QuEquIXUZlnSJ082CazwKeyzIQsaSVIh4dY6LZC9a6vUc5hysFICsIu9NTYHBfx2nB_NZ025LQv-upfxjctq_RW7GrJJOumFwm1xx9R1y_Siem98lvw7DZUjaeAqarHTVIDszbWo6XS7oedWxMZ07ihXmsYwLkJbCYhy5B0BS1RRyReorSBfpT_CPFnubVT6IZs0PRhcNdIX7HQwpH0Jvyxof7Grf0AndcEbT7r7MPXKy_-Hr-wMW32NgRhT5ggk3Ft46z8feqsJpxaW0o9xmRktltTTCmYQrJ8DQMncyMypJtfGZ07mHD_w-GdRN7XYIzYTQXEPqYbnPYITIkYWlSmEKaJ0qqYaEr0xRmkhWjm9mzMpwAidg0dJptkQDltGAQ8LWreYdWcd_8O_QymssUm2HL5qLaRk9t8y5z7MkEVb5EfyjYiydzROr8jw1aWKhk6c4Rsru3uo6YJQTgdRrSNc3JM8DAnVfYz3PVC3btjz89O0SoC_HlwF97oFeRZBvQGdGxYsWoHnk-uohX_aQ047pfBtwtweEEGR64h30j5WO23LjrNBy5TPbxc_WYuwUK_5q1ywDBrPhokiH5EHnYms7ccELGVrLnvP1DNmX1NVZ4E5P8MkBIfjDf_-uR-RGCtks1gSmYpcMFhdL9xiyz4V-EkLMb5Ssh60 priority: 102 providerName: ProQuest |
| Title | Impact of antibiotics on gut microbiome composition and resistome in the first years of life in low- to middle-income countries: A systematic review |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/37368871 https://www.proquest.com/docview/2838323871 https://www.proquest.com/docview/2830663662 https://pubmed.ncbi.nlm.nih.gov/PMC10298773 https://doaj.org/article/53f54117daf04ca698ed51da552c21d5 http://dx.doi.org/10.1371/journal.pmed.1004235 |
| Volume | 20 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1tb9MwELa2TkJ8mXhfYRSDEHzK1MRJ7CIh1KFNG6gFBkP9Fjl-KZG6pDStYP-DH8ydkwaCOrEvVdV7bKV3Oftsn58j5LkUQga-Cb2-VakXplJ7qTLK04GyBubrOHabOaNxfHIevptEky2yrtlaK7DcuLTDelLni9nBz--Xb8DhX7uqDdxfNzqYw_yBp_4QIUTbZAfmJo6uOgqbc4Vg0B_06wt0V7VsTVCOx78ZrTvzWVFuCkX_zaj8a4o6vkV269iSDquX4TbZMvkdcmNUn57fJb9O3ZVIWlgK-szSrECOZlrkdLpa0ous4mS6MBTzzOtkLkBqCktyZCAASZZTiBipzSBopJfgJSX2NsusE82KHx5dFtAV7np4SPzgelvlWLarfEWH9A9zNK1uzdwj58dHX96eeHVVBk_xOFp63Ay41caygdUyNqlkQuh-pEOVCqlTobhRPpOGg7lFZESopB-kyoYmjSx8YfdJJy9ys0doyHnKUghANLMhvCeir2HBEqsYWgdSyC5ha1MkqqYsx8oZs8Sdw3FYulSaTdCASW3ALvGaVvOKsuM_-EO0coNFwm33Q7GYJrX_JhGzUej7XEvbh38UD4TRka9lFAUq8DV08gTfkaS6vdoMG8mQIwEbkvZ1yTOHQN3nmNUzlauyTE4_fL0G6PP4OqCzFuhlDbIF6EzJ-roFaB4Zv1rIFy3ktOI73wTcbwFhIFIt8R76x1rHZQKRK8wXDJbk0HLtM5vFTxsxdop5f7kpVg6DMXEcB13yoHKxxk6Ms1i41qLlfC1DtiV59s0xqPtYeIBz9vDqR35EbgYQz2JWYMD3SWe5WJnHEH8u0x7Z5hPeIzuHR-OPZz23iwOf7z-JnhtsfgPMiI4m |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtQwELXKVgJeEPcuFGoQl6fQTZzEXiSEWmjVpe2CekF9C44vS6RtsjS7qvoffAffyIyTTQmqoC99W62PrcQzHo-dmTOEvJBCyMA3odezKvXCVGovVUZ5OlDWwH4dx-4yZ3cYbx2Gn46iowXya54Lg2GVc5voDLUuFN6Rr8I2CMrHwL9_P_nhYdUo_Lo6L6FRqcW2OTuFI1v5bvAR5PsyCDY3Dj5seXVVAU_xOJp63PS51cayvtUyNqlkQuhepEOVCqlTobhRPpOGw-OKyIhQST9IlQ1NGln4wWDca2QxZHCU6ZDF9Y3hl73miNfvuVsd5D3z_IDzOlmPcX-11o03E9jlMDYB_JiotRm6mgHNztCZjIvyIrf37-jNP7bDzdvkVu3H0rVK8e6QBZPfJdd36y_198jPgUu_pIWlILsszQrkg6ZFTkezKT3OKv6nY0Mxpr0OHAOkpnD8R7YDaMlyCt4ptRk4qPQMpr7E0caZdU3j4tSj0wKGwhsWD0km3GizHEuElW_pGj1nqaZVhs59cnglsnpAOnmRmyVCQ85TloKzo5kNQSdFT8PhKFYx9A6kkF3C5qJIVE2PjlU6xon75sfhmFTNbIICTGoBdonX9JpU9CD_wa-jlBssknu7P4qTUVLbiiRiNgp9n2tpe_BGcV8YHflaRlGgAl_DICuoI0mVKduYqGSNI9kbEgR2yXOHwLnPMYJoJGdlmQw-f70EaH94GdBeC_S6BtkC5kzJOrUDZh7ZxVrIVy3kqOJWvwi43AKC0VOt5iVcH_M5LpNz8wA952vm4uZnTTMOijGGuSlmDoP-dxwHXfKwWmKNnBhnsXC9RWvxtQTZbsmz746t3cciB5yzR_9-rhVyY-tgdyfZGQy3H5ObAfjSGJEY8GXSmZ7MzBPwfafp09rgUPLtqm3cb_WTylI |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGkSZeEPcVBjOIy1NYEyexi4RQYUwrYwUBQ30Lji8lUpeUptW0_8Gv4ddxjpO2BFWwl71V9WfLOcc-PraPv0PIYymEDHwTeh2rUi9MpfZSZZSnA2UNrNdx7A5zjgbxwXH4bhgNN8ivxVsYDKtc2ERnqHWh8Ix8F5ZBGHwM_PtdW4dFfNzbfzX54WEGKbxpXaTTqIbIoTk7he1b-bK_B7p-EgT7b7-8OfDqDAOe4nE087jpcquNZV2rZWxSyYTQnUiHKhVSp0Jxo3wmDYeui8iIUEk_SJUNTRpZ-MGg3UvkMmeRj3OMD1ebvW7Hne8gA5rnB5zXz_YY9L8eJc8nsN5hlAJ4NFFjWXTZA5ZrRGsyLsp1DvDfcZx_LIz718jV2qOlvWoIXicbJr9BNo_qO_ub5GffPcSkhaWgxSzNCmSGpkVOR_MZPckqJqgTQzG6vQ4hA6SmU1Mi7wGUZDkFP5XaDFxVegaCL7G1cWZd0bg49eisgKbwrMVDugnX2jzHZGHlC9qjK75qWr3VuUWOL0RTt0krL3KzRWjIecpScHs0syGMTtHRsE2KVQy1Aylkm7CFKhJVE6Vjvo5x4m7_OGyYKskmqMCkVmCbeMtak4oo5D_416jlJRZpvt0fxXSU1FYjiZiNQt_nWtoOfFHcFUZHvpZRFKjA19DIDo6RpHozuzRWSY8j7RtSBbbJI4dA2ec4aUZyXpZJ_8PXc4A-D84D-tQAPatBtgCZKVk_8gDJI89YA_m0gRxVLOvrgNsNIJg_1SjewvmxkHGZrAwF1FzMmfXFD5fF2ChGG-ammDsMeuJxHLTJnWqKLfXEOIuFqy0ak6-hyGZJnn13vO0-pjvgnN39d792yCZYtuR9f3B4j1wJwKnG0MSAb5PWbDo398EJnqUPnLWh5NtFm7ffn9XNIg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+antibiotics+on+gut+microbiome+composition+and+resistome+in+the+first+years+of+life+in+low-+to+middle-income+countries%3A+A+systematic+review&rft.jtitle=PLoS+medicine&rft.au=Charlie+C.+Luchen+https%3A%2F%2Forcid.org%2F0000-0002-3093-4635&rft.au=Mwelwa+Chibuye+https%3A%2F%2Forcid.org%2F0000-0002-7609-9698&rft.au=Rene+Spijker+https%3A%2F%2Forcid.org%2F0000-0003-4445-1201&rft.au=Michelo+Simuyandi+https%3A%2F%2Forcid.org%2F0000-0002-7348-2835&rft.date=2023-06-27&rft.pub=Public+Library+of+Science&rft.eissn=1549-1676&rft.volume=20&rft.issue=6&rft_id=info:doi/10.1371%2Fjournal.pmed.1004235&rft.externalDocID=2838323871 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1549-1676&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1549-1676&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1549-1676&client=summon |